Login to Your Account

Tarceva Trial Proves Positive, Pushes OSI, Genentech Stocks

By Aaron Lorenzo

Tuesday, April 27, 2004
Investors adored results from a Phase III trial of an experimental cancer drug, significantly driving up stock prices of two of the companies involved in its development. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription